Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000932 · ClinicalTrials.gov registry record
A Study of the Long-Term Outcomes of HIV-Positive Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 3,669
- Enrollment target
NCT00000932: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000932 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 3,669 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000932 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 3,669 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information about life spans and HIV-related illnesses in multiple groups of HIV-positive patients with varying anti-HIV treatment experience, including no treatment at all. Anti-HIV treatment has been successful in slowing disease progression in many patients. However, there are still questions regarding the best way to use anti-HIV drugs. This study is designed to provide long-term monitoring of patients who have already received anti-HIV treatment as well as patients who are just beginning treatment or have decided not to receive treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,669 participants |
| Start Date | 1999-03 |
| Est. Completion | 2006-09 |
What the finished NCT00000932 record still lists
NCT00000932 is an observational study that tracks outcomes without assigning an intervention. Its 3,669 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00000932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000932 about?
NCT00000932 is a clinical study titled "A Study of the Long-Term Outcomes of HIV-Positive Patients". The purpose of this study is to collect information about life spans and HIV-related illnesses in multiple groups of HIV-positive patients with varying anti-HIV treatment experience, including no treatment at all. Anti-HIV treatment has been successful in slowing disease progression in many patient...
What is the current status of trial NCT00000932?
This trial is currently completed. The enrollment target is 3,669 participants. The study started on 1999-03. Estimated completion is 2006-09.
Who is sponsoring clinical trial NCT00000932?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
- NCT07249398 · 3,650 participants · NA
Influence of Social Media Ads on Food Choice - Master Protocol
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia